• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新冠病毒疫苗接种后的止血变化：它们会促发血栓前状态吗？

Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state?

作者信息

Rungjirajittranon Tarinee, Nakkinkun Yupa, Suwanawiboon Bundarika, Chinthammitr Yingyong, Owattanapanich Weerapat, Ruchutrakool Theera

机构信息

Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Hum Vaccin Immunother. 2025 Dec;21(1):2439627. doi: 10.1080/21645515.2024.2439627. Epub 2024 Dec 19.

DOI:10.1080/21645515.2024.2439627
PMID:39699990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11660298/
Abstract

TCTR20240812005.

摘要

TCTR20240812005

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/e3773baefd3e/KHVI_A_2439627_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/5a249342f802/KHVI_A_2439627_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/37f0b1a2c45d/KHVI_A_2439627_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/6d41d14d6849/KHVI_A_2439627_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/e3773baefd3e/KHVI_A_2439627_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/5a249342f802/KHVI_A_2439627_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/37f0b1a2c45d/KHVI_A_2439627_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/6d41d14d6849/KHVI_A_2439627_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd3f/11660298/e3773baefd3e/KHVI_A_2439627_F0004_OC.jpg

相似文献

1
Hemostatic changes following COVID-19 vaccination: Do they promote a pro-thrombotic state?新冠病毒疫苗接种后的止血变化：它们会促发血栓前状态吗？
Hum Vaccin Immunother. 2025 Dec;21(1):2439627. doi: 10.1080/21645515.2024.2439627. Epub 2024 Dec 19.
2
Anti-PF4 positivity and platelet activation after Ad26.COV2·S vaccination in Brazil.巴西 Ad26.COV2·S 疫苗接种后抗 PF4 阳性和血小板活化。
Vaccine. 2024 Nov 14;42(25):126175. doi: 10.1016/j.vaccine.2024.126175. Epub 2024 Aug 5.
3
Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.新冠病毒疫苗接种后的炎症和血小板活化 - 疫苗诱导免疫性血小板减少症和血栓形成的可能机制。
Front Immunol. 2021 Nov 23;12:779453. doi: 10.3389/fimmu.2021.779453. eCollection 2021.
4
Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms.慢性髓系肿瘤患者对新冠病毒疫苗接种的抗体反应受损。
Br J Haematol. 2021 Sep;194(6):1010-1015. doi: 10.1111/bjh.17644. Epub 2021 Jun 24.
5
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
6
Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.一种雾化型腺病毒 5 型载体新冠疫苗（Ad5-nCoV）在成年人中的安全性、耐受性和免疫原性：一项开放标签、随机 1 期临床试验的初步报告。
Lancet Infect Dis. 2021 Dec;21(12):1654-1664. doi: 10.1016/S1473-3099(21)00396-0. Epub 2021 Jul 26.
7
Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).接种新型冠状病毒疫苗（ChAdOx1 nCoV-19）后发生免疫性血小板减少性紫癜
Blood. 2021 Sep 16;138(11):996-999. doi: 10.1182/blood.2021012790.
8
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
9
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
10
SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.SARS-CoV-2 mRNA 疫苗在免疫原性初免和预免疫人群中引发不同的反应。
Front Immunol. 2021 Sep 27;12:728021. doi: 10.3389/fimmu.2021.728021. eCollection 2021.

本文引用的文献

1
Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England.英格兰 4600 万成年人中不同剂量 COVID-19 疫苗接种的心血管安全性队列研究。
Nat Commun. 2024 Jul 31;15(1):6085. doi: 10.1038/s41467-024-49634-x.
2
Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial.肌肉注射或皮内注射mRNA-1273新冠疫苗后的凝血和炎症反应：一项随机试验的二次分析
Res Pract Thromb Haemost. 2024 Apr 24;8(3):102419. doi: 10.1016/j.rpth.2024.102419. eCollection 2024 Mar.
3
The dos, don'ts, and nuances of thrombophilia testing.
血栓形成倾向检测的注意事项。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):593-599. doi: 10.1182/hematology.2023000491.
4
Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.血栓性抗 PF4 免疫性疾病：HIT、VITT 及其他。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):1-10. doi: 10.1182/hematology.2023000503.
5
Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series.新型冠状病毒肺炎mRNA疫苗接种后的血栓形成：病例系列
Cureus. 2023 Jul 4;15(7):e41371. doi: 10.7759/cureus.41371. eCollection 2023 Jul.
6
Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia.COVID-19 mRNA 疫苗接种后的不良反应：心血管并发症、血栓形成和血小板减少症的系统评价。
Immun Inflamm Dis. 2023 Mar;11(3):e807. doi: 10.1002/iid3.807.
7
Head-to-head comparison of four COVID-19 vaccines on platelet activation, coagulation and inflammation. The TREASURE study.四种 COVID-19 疫苗对血小板活化、凝血和炎症的头对头比较。TREASURE 研究。
Thromb Res. 2023 Mar;223:24-33. doi: 10.1016/j.thromres.2023.01.015. Epub 2023 Jan 18.
8
Vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症。
Blood. 2023 Apr 6;141(14):1659-1665. doi: 10.1182/blood.2022017696.
9
SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people.在看似健康的人群中，新型冠状病毒2型疫苗与高凝状态无关。
Res Pract Thromb Haemost. 2023 Jan;7(1):100002. doi: 10.1016/j.rpth.2022.100002. Epub 2022 Nov 25.
10
Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines.接受腺病毒载体新冠疫苗的受种者发生有或无血小板减少的血栓形成事件。
Front Cardiovasc Med. 2022 Sep 29;9:967926. doi: 10.3389/fcvm.2022.967926. eCollection 2022.